Depo-Medrone (Methylprednisolone) and Kenalog (Triamcinolone) administered by intra-muscular injection as treatment for hayfever are prohibited in sport and therefore their use requires the athlete and their physician to strictly adhere to the TUE Policy. The TUE Policy is available at www.irishsportscouncil.ie/tue It is the responsibility of all athletes using the post-test TUE route to ensure [...]
HMG-CoA reductase inhibitors – Risk of new onset diabetes in patients already at increased risk of developing diabetes HMG-CoA reductase inhibitors*, commonly known as statins, are used to lower lipids in the blood. Following publication of a meta-analysis which reported that therapy with statins overall was associated with a slightly increased risk for the development [...]
There are many medical treatment options available for glaucoma. When selecting a treatment, it is important to take into account efficacy, mode of action, safety, tolerability, contraindications, quality of life, adherence and cost. Management algorithm for glaucoma medications Recommendations Assess each eye individually when selecting therapy After diagnosis measure untreated intraocular pressure (IOP) more than once before initiating IOP-lowering treatment If feasible, a therapeutic trial on [...]
Reference: EUROPEAN GLAUCOMA SOCIETY Terminology and Guidelines for Glaucoma 3rd edition, 2008.
Company: Teva Pharmaceuticals Ireland. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Budesonide 0.5mg/2ml. Description: White to off-white nebuliser suspension. Presentation: 0.5mg/2ml-20, €23.95. Indication: Treatment of bronchial asthma in patients where use of a pressurised inhaler or dry powder formulation is unsatisfactory or inappropriate. Pharmacology: Budesonide is a glucocorticosteroid with a powerful local anti-inflammatory action. [...]
Company: Clonmel Healthcare Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Levetiracetam 250mg, 500mg, 1000mg. Description: Blue, yellow or white, oblong, biconvex, film-coated tablets with breaking notch on one side, respectively. Presentation: 250mg-60, €29.78; 500mg-60, €58.12; 1000mg-60, €110.81. Indications: Monotherapy in partial onset seizures with or without secondary generalisation (≥16 years) in newly diagnosed [...]
Company: Phoenix Healthcare Ltd. Legal category: Prescription. GMS. Sport prohibited in competition. Active ingredient: Tablets: Methylphenidate HCl 5mg, 10mg, 20mg. Capsules: Methylphenidate HCl 5mg, 10mg, 20mg, 30mg, 40mg. Description: Tablets: White, round tablets marked S, M or L respectively. Capsules: Modified-release, hard capsules containing white and blue pellets. White, mauve/white, mauve, violet/light grey, violet/grey, respectively. [...]
Company: Rowex Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Quetiapine (fumarate) 25mg, 100mg, 200mg, 300mg. Description: Pink, yellow, white, (all round), or white (oval) film-coated tablets, respectively. 100mg, 200mg, 300mg: Scored on one side, may be divided. Presentation: 25mg-60, €35.65; 100mg-60, €101.86; 200mg-60, €116.13; 300mg-60, €188.82. Indications: Treatment of schizophrenia. Treatment of moderate [...]
Company: Clonmel Healthcare Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Quetiapine (fumarate) 25mg, 100mg, 200mg, 300mg. Description: Film-coated tablets. 25mg, 100mg, 200mg: Peach, yellow or white, round, respectively. 300mg: White and capsule-shaped, scored on one side. Presentation: 25mg-60, €35.66; 100mg-60, €101.88; 200mg-60, €116.15; 300mg-60, €188.84. Indications: Treatment of schizophrenia. Treatment of moderate to [...]
Loading ...
